China Digital PCR (dPCR) and Real-Time PCR (qPCR) Market, Size, Share, Analysis Report & Forecast to 2026

China digital PCR (dPCR) and real-time PCR (qPCR) market is estimated to grow at a CAGR of 9.3% during the forecast period. The market in China has both medium and long-term potential owing to the increasing prevalence of chronic diseases and the large aging population base. Furthermore, the Chinese economy is becoming an R&D-intensive economy on all fronts, which is the major factor for the growth of the life science industry in China. An aging population and the growing prevalence of cancer among youth and middle age population are resulting in the growth of the life science industry in China.

Free Sample Copy @ https://www.omrglobal.com/request-sample/china-digital-pcr-and-real-time-pcr-market

According to the World Health Organization (WHO), China recorded nearly 4.3 million cancer cases in 2018. China is one of the major countries with considerable biologics production. The Chinese market generates much of the revenue from the largest life science companies across the globe. Droplet digital PCR (ddPCR) has become one of the most accurate and reliable tools to study genetic alterations in a broad range of cancers owing to its high sensitivity and specificity. Therefore, it has a crucial application in cancer drug development, which in turn, is driving the growth of the market.

A Full Report of China Digital PCR (dPCR) and Real-Time PCR (qPCR) Market is Available at:
https://www.omrglobal.com/industry-reports/china-digital-pcr-and-real-time-pcr-market

The companies operating in the market include Abbott Laboratories, Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche AG, QIAGEN N.V., and Hangzhou Longgene Scientific Instruments Co., Ltd. The growth strategies adopted by these players such as acquisitions, mergers, investment in R&D activities and product launches are estimated to have a positive impact on the growth of the PCR technologies such as dPCR and qPCR in the country. For instance, in November 2018, Thermo Fisher Scientific, opened its first Bioprocess Design Center in Shanghai, China. It is part of a strategy to set up a center of excellence where the scientists of the company can connect and partner with biologic developers to design optimal bioprocessing solutions.

China Digital PCR (dPCR) and Real-Time PCR (qPCR) Market – Segmentation
by Technology
Quantitative PCR (qPCR)
Digital PCR (dPCR)
by Product
Reagents and Consumables
Instruments
Software
by Application
Research Application
Clinical Application
Forensic Application

Company Profiles
Abbott Laboratories, Inc.
Agilent Technologies, Inc.
Becton, Dickinson and Co.
BioMérieux S.A.
Bio-Rad Laboratories, Inc.
Eppendorf AG
F. Hoffmann-La Roche AG
Hangzhou Longgene Scientific Instruments Co., Ltd.
JN Medsys
Merck KGaA
QIAGEN N.V.
Takara Bio Inc.
Thermo Fisher Scientific Inc.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/china-digital-pcr-and-real-time-pcr-market

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com 
Contact no: +91 780-304-0404

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.